易明医药: 关于公司持股5%以上股东减持触及1%的公告

Core Viewpoint - The major shareholder of Xizang Yiming Xiya Pharmaceutical Technology Co., Ltd., Mr. Zhou Zhan, has reduced his shareholding by 1% through a series of transactions, which does not affect the company's control or governance structure [1][2]. Summary by Sections Shareholder Reduction Announcement - Mr. Zhou Zhan plans to reduce his shareholding by up to 3,590,000 shares, representing 1.8828% of the total share capital, within three months from the announcement date [1]. Share Reduction Progress - From June 11 to June 18, 2025, Mr. Zhou Zhan reduced his holdings by 1,906,777 shares, accounting for 1% of the total share capital and 1.02% of the total share capital excluding shares in the repurchase account [2]. - After the reduction, Mr. Zhou Zhan holds 12,454,925 shares, which is 6.53% of the total share capital and 6.66% excluding repurchased shares [2]. Impact on Company Control - The reduction in shareholding will not lead to any change in the company's control or significantly impact its governance structure and ongoing operations [2].